Do anti-angiogenic therapies prevent brain metastases in advanced renal cell carcinoma?

Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma

2007 • 3,560 citations

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

2007 • 2,222 citations

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

2009 • 2,104 citations

Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma

2002 • 1,520 citations

Sorafenib for Treatment of Renal Cell Carcinoma: Final Efficacy and Safety Results of the Phase III Treatment Approaches in Renal Cancer Global Evaluation Trial

2009 • 1,078 citations

Phase III Trial of Bevacizumab Plus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma (AVOREN): Final Analysis of Overall Survival

2010 • 785 citations

Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease

2003 • 766 citations

Randomized Phase II Trial of First-Line Treatment With Sorafenib Versus Interferon Alfa-2a in Patients With Metastatic Renal Cell Carcinoma

2009 • 480 citations

Chemotherapy Delivery Issues in Central Nervous System Malignancy: A Reality Check

2007 • 390 citations

Renal cell carcinoma: Survival and prognostic factors

1986 • 323 citations

RENAL CELL CARCINOMA: MANAGEMENT OF ADVANCED DISEASE

1999 • 272 citations

Stereotactic radiosurgery for brain metastasis from renal cell carcinoma

1998 • 198 citations

External radiation of brain metastases from renal carcinoma: A retrospective study of 119 patients from the M. D. Anderson Cancer Center

1997 • 177 citations

Brain metastasis from renal cell carcinoma

2008 • 154 citations

Sunitinib in metastatic renal cell carcinoma patients with brain metastases

2010 • 139 citations

Targeting mTOR Pathways in Human Malignancies

2012 • 105 citations

Incidence of brain metastases in renal cell carcinoma treated with sorafenib

2009 • 102 citations

Long-lasting successful cerebral response with sorafenib in advanced renal cell carcinoma

2008 • 40 citations

Successful treatment of a brain-metastasized renal cell carcinoma.

2009 • 13 citations

Phase II trial of sunitinib in renal cell cancer with untreated brain metastases.

2011 • 7 citations